Physician profile
Carl Spirazza
NPI 1881784833
$23,416.95
in general payments reported to CMS, 2019-2025
56 companies · $1,571 in 2025
The $1,571 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,971 · 2021: $2,351 · 2022: $1,290 · 2023: $1,748 · 2024: $1,670 · 2025: $1,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,989.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $6,446.71 | 2019-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $4,145.68 | 2019-2020 | |
| Novo Nordisk INC | $1,341.12 | 2019-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $1,295.48 | 2019-2025 | Vraylar, Synthroid, Ubrelvy |
| Lilly USA, LLC | $1,289.34 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Astrazeneca Pharmaceuticals LP | $946.62 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $725.15 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $701.49 | 2019-2025 | |
| Amarin Pharma, INC. | $693.96 | 2019-2022 | |
| Amgen INC. | $686.92 | 2019-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $586.19 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $508.43 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $322.38 | 2019-2023 | Vaxneuvance, Gardasil 9 |
| Takeda Pharmaceuticals U.S.A., INC. | $313.86 | 2019-2022 | |
| Esperion Therapeutics, INC. | $312.21 | 2021-2025 | Nexletol |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $207.59 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $207.28 | 2020-2024 | |
| Allergan, INC. | $201.99 | 2019-2020 | |
| Abbott Laboratories | $180.15 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $145.82 | 2020-2023 | Spravato |
| Biohaven Pharmaceuticals, INC. | $141.96 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $140.87 | 2019-2024 | |
| Relievant Medsystems, INC. | $140.76 | 2023 | Intracept |
| Medtronic, INC. | $134.13 | 2024 | Endurant Iis |
| Philips North America LLC | $133.49 | 2019 | |
| Jazz Pharmaceuticals INC. | $126.52 | 2019-2021 | |
| Stryker Corporation | $121.02 | 2025 | Blueprint Patient Specific Instrumentation |
| Aerin Medical INC. | $117.27 | 2023 | |
| Alnylam Pharmaceuticals INC. | $105.88 | 2023-2025 | Onpattro |
| Astellas Pharma US INC | $98.25 | 2023-2025 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $90.14 | 2025 | Caplyta |
| Dexcom, INC. | $86.90 | 2024-2025 | Dexcom G6 Transmitter |
| Adlon Therapeutics L.P. | $86.29 | 2020-2021 | |
| Boston Scientific Corporation | $73.43 | 2019 | |
| Arbor Pharmaceuticals, INC. | $47.08 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $41.70 | 2024-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $39.99 | 2022 | |
| Idorsia Pharmaceuticals US INC | $36.51 | 2023-2024 | Quviviq |
| Radius Health, INC. | $36.47 | 2019-2020 | |
| Edwards Lifesciences Corporation | $30.61 | 2024 | |
| Antares Pharma, INC. | $30.54 | 2021 | |
| Inspire Medical Systems, INC. | $28.87 | 2024 | Inspire |
| Nevro Corp. | $26.55 | 2022 | |
| Corcept Therapeutics | $23.54 | 2025 | Korlym |
| Horizon Therapeutics Plc | $22.48 | 2021 | |
| C2n Diagnostics, LLC | $21.86 | 2025 | Precivityad2 |
| Genentech USA, INC. | $21.53 | 2024 | Xolair |
| Sanofi Pasteur INC. | $20.62 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $20.21 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.22 | 2022 | |
| Almatica Pharma LLC | $19.21 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.42 | 2019 | |
| Dermira, INC. | $16.72 | 2020 | |
| Intra-Sana Laboratories | $16.10 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Currax Pharmaceuticals LLC | $13.25 | 2022 | |
| Insightec,INC | $10.19 | 2024 | Exablate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Spirazza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.